Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Please Try Again {{ error }}

Send my password

SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.

biOasis Technologies Ord Shs V.BTI.H

Alternate Symbol(s):  BIOAF

Bioasis Technologies Inc. is a Canada-based biopharmaceutical company focused on research and development of technologies and products intended for the treatment of patients with nervous system, including central nervous system, diseases and disorders. The Company is engaged in the development of its xB 3 platform, which is a peptide-based technology, for the transport of therapeutic agents, in particular biological products, across the blood-brain barrier (BBB). It is focused on both orphan drug indications, including brain cancers, and rare genetic neurodegenerative diseases and neuroinflammatory conditions. The Company is also focused on its Epidermal Growth Factor (EGF) platform for treating rare and orphan neurodegenerative and neuroinflammatory disorders. EGF is a protein that stimulates cell growth and differentiation, notably for myelin producing cells. Its development programs include xB3-001: Brain Metastases, xB3-002: Glioblastoma and xB3-007: Neurodegenerative Disease.


TSXV:BTI.H - Post by User

Comment by Boomskidon Jan 10, 2023 10:11am
108 Views
Post# 35213203

RE:RE:Saltarelli is in the catbird seat...

RE:RE:Saltarelli is in the catbird seat...Don't worry about Saltarelli and his 1,378,217 options G1945G. He may very well get a much greater reward from Biodexa, or later from a private player if he follows xB3 wherever it may go.

I love poof's comment about Saltarelli, "...he's looked under the hood of Biodexa in ways that we wil never be able to."

Poof is stating what I've been saying for 18 months, that Bioasis is not disclosing much about its activities, that it's actually removing disclosures from its filings and promotional material.

And then poof has the gall to describe the potential value of the Biodexa assets of which Bioasis shareholders will own only about 6% and private interests will own more than 75%.

Imagine, he's trying to make all of that a selling point for the deal!

And then when you consider that DrDR & DrMS are free to chase xB3 and LT and The Placee wherever they may go, including to a potential new xB3-based IPO, then poof might want to take his pumping to more fertile grounds because these barren grounds are unfit for human habitation.

If Saltarelli is a mastermind behind this sellout then I can't see DrDR remaining in the mix for long. I suspect that DrMS has more team-player inclinations than DrDR does and that this difference between the two could be soon detected by the private interests.

I would wish DrDR and DrMS good luck but beenthere needs those wishes more than they do. DrDR and DrMS are well set up, no luck needed now.

jd
<< Previous
Bullboard Posts
Next >>